Skip to main content

Latest SEC Filings — Page 159

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Avalyn Pharma Finalizes Post-IPO Corporate Charter and Bylaws
Form 8-KAVLN · Form 8-K · 9d ago
Origin Materials Announces Plan to Dissolve and Liquidate, CEO Steps Down Amidst 59% Workforce Reduction
ProForm 8-KORGN · Form 8-K · 9d ago
IRADIMED Reports Strong Q1 Financials with Double-Digit Growth and Healthy Liquidity
ProForm 10-QIRMD · Form 10-Q · 9d ago
Eledon Pharmaceuticals Files $500M Universal Shelf, Updates $75M ATM Program
ProForm S-3ELDN · Form S-3 · 9d ago
Shareholders to Vote on New Investment Adviser and Board Following Failed Reorganization
ProForm PRE 14AMIN · Form PRE 14A · 9d ago
Third Party Pays $850K Legal Settlement for Context Therapeutics, Resolving Stockholder Lawsuit
Form 8-KCNTX · Form 8-K · 9d ago
Aon Reports Strong Q1 2026 Results with 27% EPS Growth and Significant Cash Flow Increase
ProForm 10-QAON · Form 10-Q · 9d ago
Senseonics Prices $80M Public Offering at Deep Discount, Addressing Going Concern Risk
ProForm 424B5SENS · Form 424B5 · 9d ago
Enterprise Financial Services Reports Mixed Q1 Results with Improved Asset Quality
Form 10-QEFSC · Form 10-Q · 9d ago
InspireMD Recalls CGuard Prime Delivery System, Withdraws 2026 Revenue Guidance Amidst Going Concern Warning
ProForm 8-KNSPR · Form 8-K · 9d ago
Atlassian Reports Strong Q3 Revenue Growth, Announces Major Restructuring for AI Focus, and Completes $1.5B Share Buyback
ProForm 10-QTEAM · Form 10-Q · 9d ago
Senti Biosciences Secures Up to $40M in Highly Dilutive Convertible Notes, Leading to Change of Control
ProForm 8-KSNTI · Form 8-K · 9d ago
National Bankshares Announces $6.57M Pre-Tax Gain from Sale of Bearing Insurance Group Interest
ProForm 8-KNKSH · Form 8-K · 9d ago
AutoNation Reports Strong Q1 EPS Growth Driven by Finance & Service, Continues Share Buybacks
ProForm 10-QAN · Form 10-Q · 9d ago
Mattel Reports Q1 Profit Driven by Strategic Acquisition Gain Amidst Operational Headwinds
Form 10-QMAT · Form 10-Q · 9d ago
TTM Technologies Reports Strong Q1 2026 Results with 30% Revenue Growth Driven by AI and Defense
ProForm 10-QTTMI · Form 10-Q · 9d ago
Repay Holdings Faces Proxy Contest, Proposes Significant Equity Plan Dilution
ProForm PREC14ARPAY · Form PREC14A · 9d ago
Selling Stockholders Register Over 9.6M Shares for Resale, Posing Significant Dilution Risk Amidst Going Concern Warning
ProForm S-1LABT · Form S-1 · 9d ago
Tvardi Therapeutics Files $200M Mixed Shelf and $12.5M ATM Program to Raise Capital Amidst Going Concern Warning
ProForm S-3TVRD · Form S-3 · 9d ago
Dror Ortho-Design Secures $275K Private Placement of 0% Convertible Debentures and Warrants
ProForm 8-KDROR · Form 8-K · 9d ago
Netcapital Secures $275K in High-Cost, Dilutive Financing Amidst Going Concern Warning
ProForm 8-KNCPL · Form 8-K · 9d ago
NEXTNRG Secures $1M High-Interest Venture Debt at 203% APR, CEO Personally Guarantees All Assets
ProForm 8-KNXXT · Form 8-K · 9d ago
Oxford Square Capital Reports 21.9% NAV Decline and Increased Net Loss in Q1 2026
ProForm 10-QOXSQ · Form 10-Q · 9d ago
Stockholders Approve Reverse Stock Split and Expanded Equity Plan
ProForm 8-KELOX · Form 8-K · 9d ago
Shareholders Approve 25% Threshold for Special Meetings, Enhancing Governance
Form 8-KRVTY · Form 8-K · 9d ago
Stockholders Approve New Equity Incentive Plan Authorizing Over 2.3M Shares
Form 8-KSAH · Form 8-K · 9d ago
Atara Biotherapeutics Receives Nasdaq Delisting Notice for Failing Minimum Market Value Requirement
ProForm 8-KATRA · Form 8-K · 9d ago
LEIFRAS Completes Acquisition of Child Development & Day Care Business, Expands Operations in Japan
Form 6-KLFS · Form 6-K · 9d ago
MFS Government Markets Income Trust Proposes New Investment Adviser and Board After Failed Reorganization
ProForm PRE 14AMGF · Form PRE 14A · 9d ago
Roku Reports Strong Q1 2026 Results with Return to Profitability, Robust Free Cash Flow, and $100M Share Repurchase
ProForm 10-QROKU · Form 10-Q · 9d ago